Is accelerated, high-dose theta burst stimulation a panacea for treatment-resistant depression?

19Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A recent study by Williams et al. (Williams NR, Sudheimer KD, Bentzley BS, Pannu J, Stimpson KH, Duvio D, Cherian K, Hawkins J, Scherrer KH, Vyssoki B, DeSouza D, Raj KS, Keller J, Schatzberg AF. Brain 141: e18, 2018) used accelerated, high-dose intermittent theta burst stimulation (iTBS) to treat highly treatment-resistant depression patients. Remarkably, most patients remitted, but the durability of therapeutic response was weak and all patients relapsed within 2 wk posttreatment. This mini-review examines the “fast on, fast off” effects of accelerated, high-dose iTBS for depression and suggests a new treatment that would combine the strengths of multiple extant iTBS protocols.

Cite

CITATION STYLE

APA

Caulfield, K. A. (2020). Is accelerated, high-dose theta burst stimulation a panacea for treatment-resistant depression? Journal of Neurophysiology. American Physiological Society. https://doi.org/10.1152/jn.00537.2019

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free